Brig Bio

BRIG BIO develops dairy proteins through precision fermentation for medical nutrition, with the goal of supporting patient health and nutritional care through a more resilient and sustainable protein supply. The company’s first commercial protein is Alpha-lac, and it is building a broader platform that can scale new strains and create customer-specific downstream processing solutions for medical nutrition manufacturers. BRIG BIO emphasizes high-quality protein, functionality, taste, purity, stability, supply resilience, and faster innovation for its partners. Its approach is designed for clinical and medical food applications, where consistent quality and patient compliance matter. What the company does BRIG BIO works on producing milk proteins without cows by using microorganisms and precision fermentation. It positions this as a complementary alternative to traditional dairy, especially for the medical nutrition sector, where demand for reliable, high-quality protein is growing. The company says its platform is aimed at delivering ingredients that can be tailored to specific applications and processing conditions in medical nutrition. Who makes up the team BRIG BIO describes itself as a small, highly dedicated team with deep dairy and protein-industry experience. The team was spun out of FrieslandCampina and combines decades of proven dairy expertise with a new precision-fermentation approach. Publicly highlighted team members include Dr. Florian Hamann, Head of Processing; Mila de Boer Head of Precisio Fermentation, Benjamin Maclean, COO & Co-Founder; and Steven Welle, CEO & Co-Founder. Company mission BRIG BIO’s mission is to secure high-quality proteins for medical foods and medical nutrition. The company aims to deliver better proteins for patients while respecting nature, using scalable and geo-independent production to improve supply resilience and sustainability. It presents its work as helping build a more robust protein system that can support patient care and future nutrition needs.